Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Total 13F shares
-
29,099,816
-
Share change
-
+2,106,880
-
Total reported value
-
$568,637,489
-
Put/Call ratio
-
66%
-
Price per share
-
$19.54
-
Number of holders
-
124
-
Value change
-
+$41,402,106
-
Number of buys
-
77
-
Number of sells
-
38
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2018
As of 30 Jun 2018 Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,099,816 shares of stock of the company.
Largest 10 holders included TRV GP III, LLC, BB BIOTECH AG, FMR LLC, BlackRock Inc., STATE STREET CORP, Casdin Capital, LLC, VANGUARD GROUP INC, HIGHLINE CAPITAL MANAGEMENT, L.P., FARALLON CAPITAL MANAGEMENT LLC, and GREAT POINT PARTNERS LLC.
This table shows 124 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.